NFKB1 and arthritic joint disease: Thus, the suppression of the NF-κB and MAPKs signaling pathway has been regarded as one of the pharmacological approaches to human diseases such as cancer, arthritis, alzheimer’s disease, asthma allergies and inflammatory diseases [3,4,5].